Status:
COMPLETED
Clinical Evaluation of Cordio Application in Adult COVID-19 Virus Positive Patients
Lead Sponsor:
Cordio Medical
Conditions:
Coronavirus Infection
Eligibility:
All Genders
18+ years
Brief Summary
Study on adult patients positive to COVID-19 virus. After signing informed consent and undergoing screening assessments, eligible patients will record few times a day several pre-defined sentences to ...
Eligibility Criteria
Inclusion
- 18+ years old
- Diagnosed with COVID-19 positive patients according to medical center guidelines, with symptoms of cough and or dyspnea. Patients that diagnosed with pneumonia, should be confirmed by X-ray and/or CT.
- Able to understand and provide written informed consent (manually or electronically or giving their consent via the telephone to the study investigator in case of isolated patients).
Exclusion
- Subjects, in the Investigator's opinion, unable to comply with the daily use of the application including mental disorders (e.g., depression, dementia).
- Patients with severe alcohol or drug use.
- Women who are pregnant or lactating.
- Participating in another investigation therapy that may interfere with study results (according to investigator discretion)
Key Trial Info
Start Date :
April 23 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 29 2021
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT04325048
Start Date
April 23 2020
End Date
September 29 2021
Last Update
December 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam Medical Center
Haifa, Israel